ABC News
ColdFlu_subindex

Experts: New Bird Flu Vaccine Looks Promising

Experts: Baxter bird flu vaccine made from lab cells instead of chicken eggs appears promising

FONT SIZE
RSS

The first experimental bird flu vaccine made from lab-grown cells instead of chicken eggs shows promise in blocking the highly lethal virus, scientists report.

In this June 5, 2008 file photo, chickens look out of their pen in a downtown neighborhood in... Expand
(AP)

The advance is good news not just for preparations in case of a pandemic, but also because it offers a way to make shots for seasonal flu much faster. That gives health officials crucial extra time to better match annual shots to the flu strains circulating.

It also would reduce dependence on the antiquated system of using millions of eggs to make flu vaccines and could cut production time roughly in half, to as little as 12 weeks, according to maker Baxter International Inc.

Results of mid-stage testing of the Baxter vaccine, Celvapan, showed two shots produced an immune response considered strong enough to protect 76 percent of healthy adults from both the H5N1 Vietnam strain it targets and the related Hong Kong strain; it appeared to protect 45 percent from a third, Indonesian strain.

Related

"I think it is a big leap forward," said Dr. Wilbur Chen, a vaccine researcher at the University of Maryland School of Medicine not involved in the study.

Since the first outbreak in Hong Kong in 1997, more than 240 people in Asia, Europe and Africa have died from bird flu, which kills about two-thirds of people infected. Nearly all had close contact with poultry, but scientists worry bird flu could mutate to a form easily spread among people, who have no natural immunity. Many experts believe a pandemic will eventually occur.

On Wednesday, Hong Kong health officials ordered the slaughter of all live poultry in street markets due to one of the largest outbreaks of the virus in birds in years.

The United States has stockpiled 23 million doses of egg-based human bird flu vaccine made by three companies; some European countries also have such stockpiles and are ordering Baxter's cell-based vaccine.

Other human vaccines — a few using cells or genetic engineering but most made from eggs — are being tested in dozens of government and commercial projects. Baxter officials say theirs is the first produced in cells that's been tested in people, and they expect to get a European Union license for Celvapan around year's end.

NEXT >
Next Story: Merck Recalls Childhood Meningitis Vaccine
Comment & Contribute

If you would like to tell us more facts about this story, please click here to send the editors of ABC News a separate email with the information you have.

More Coverage
Watch Video
1 2
Health News
Slideshows
1 2 3
Top Stories
1 2 3 4 5
ABC News Features
1